{"gene":"PDHX","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2011,"finding":"The human PDC E2/E3BP core exists as a heterogeneous population of assemblies; recombinant core produced with excess E3BP yields 40E2+20E3BP stoichiometry, while native bovine core is 48E2+12E3BP. Both cores bind E3 with 2:1 stoichiometry, and mathematical modelling indicates 48E2+12E3BP maximizes flexibility while balancing E1 and E3 binding for optimal catalysis.","method":"Analytical ultracentrifugation, small-angle neutron scattering, isothermal titration calorimetry, and mathematical modelling of recombinant and native PDC core assemblies","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with multiple orthogonal biophysical methods (AUC, SANS, ITC) in a single rigorous study","pmids":["21627584"],"is_preprint":false},{"year":2014,"finding":"The E2·E3BP core interacts with PDK1 and PDK2 at defined loci: the L2 lipoyl domain of E2 preferentially binds PDK2 over PDK1 in the context of the intact core; L3 of E3BP shows moderate interaction with both PDKs. The intact E2·E3BP core induces greater conformational plasticity in PDK1 than PDK2.","method":"H/D exchange mass spectrometry (HDX-MS) and NMR with truncated and intact E2·E3BP core proteins","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — two orthogonal structural/biophysical methods (HDX-MS and NMR) applied to the same protein complex in one study","pmids":["25436986"],"is_preprint":false},{"year":2020,"finding":"In the fungal PDC ortholog, protein X (PX; functional analog of mammalian E3BP) is located interior to the PDC core rather than substituting E2 subunits as in mammals; steric occlusion limits PX binding, resulting in predominantly tetrahedral symmetry. The PX-binding site is conserved in and specific to fungi, distinct from the mammalian E3BP mechanism.","method":"Cryo-electron microscopy reconstruction of Neurospora crassa PDC","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure with multiple symmetry analyses revealing mechanistic distinction from mammalian E3BP","pmids":["32938938"],"is_preprint":false},{"year":1999,"finding":"Autoantibodies in primary biliary cirrhosis (PBC) directed against E3BP (PDHX) are targeted exclusively to its lipoic acid-binding domain; pre-absorption of patient sera with the E3BP lipoic domain completely abolished all reactivity with the full-length protein.","method":"Recombinant protein expression of E3BP lipoic domain, ELISA, immunoblotting, and pre-absorption experiments with PBC patient sera","journal":"Hepatology (Baltimore, Md.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal serology (ELISA + immunoblot + absorption) in a single study with 45 PBC and 52 control sera","pmids":["10094940"],"is_preprint":false},{"year":2014,"finding":"miR-26a directly binds the 3′-UTR of PDHX mRNA and suppresses PDHX expression, resulting in reduced conversion of pyruvate to acetyl-CoA (decreased acetyl-CoA, increased pyruvate accumulation) in colorectal cancer cells.","method":"Dual-luciferase reporter assay for 3′-UTR targeting; Western blot and RT-PCR for protein/mRNA; metabolite assays (glucose consumption, lactate, pyruvate, acetyl-CoA) after miR-26a overexpression or inhibition in HCT116 cells","journal":"BMC cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter confirms direct 3′-UTR targeting plus multiple metabolite readouts; single lab","pmids":["24935220"],"is_preprint":false},{"year":2018,"finding":"miR-27b directly targets PDHX mRNA via its 3′-UTR and suppresses PDHX protein expression in breast cancer cells, shifting metabolism toward glycolysis (increased lactate, decreased citrate and mitochondrial oxidation) and promoting cell proliferation.","method":"Luciferase 3′-UTR reporter assay; RT-PCR; Western blot; Seahorse metabolic flux analysis; metabolite assays; cell proliferation assays after miR-27b manipulation","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct 3′-UTR validation plus orthogonal metabolic readouts; single lab","pmids":["30012170"],"is_preprint":false},{"year":2021,"finding":"miR-181b-5p directly targets PDHX mRNA (validated by dual-luciferase reporter assay), and its inhibition upregulates PDHX protein, reversing hypoxia-induced increases in glucose consumption and lactate production in gallbladder cancer cells.","method":"Dual-luciferase reporter assay; Western blot; glucose and lactate metabolite assays; CCK-8 viability and Transwell migration assays after miR-181b-5p antagomir treatment","journal":"Frontiers in oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct 3′-UTR targeting confirmed plus metabolic phenotype rescue; single lab","pmids":["34485121"],"is_preprint":false},{"year":2021,"finding":"PDHX expression is required for maintenance of pyruvate dehydrogenase (PDH) activity and ATP production in esophageal squamous cell carcinoma (ESCC); PDHX knockdown inhibits cancer stem cell proliferation and in vivo tumor growth. PDHX and CD44 are co-amplified at 11p13 and coordinately support cancer stemness.","method":"siRNA knockdown of PDHX; PDH activity assay; ATP production assay; cancer stem cell proliferation assay; in vivo xenograft tumor growth experiments","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with enzymatic activity readout plus in vivo validation; single lab","pmids":["33964039"],"is_preprint":false},{"year":2006,"finding":"Loss-of-function mutations in PDHX (encoding E3-binding protein/E3BP) cause pyruvate dehydrogenase complex deficiency; the E3BP subunit is undetectable by Western blot in patient fibroblasts carrying a homozygous deletion of exon 10 (3913 bp deletion in PDHX).","method":"Western blot of patient-derived fibroblasts; long-range PCR; direct sequencing of deletion breakpoints; PDHc activity assay","journal":"Molecular genetics and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Western blot absence of protein plus enzyme activity assay; single case report","pmids":["16843025"],"is_preprint":false},{"year":2006,"finding":"T-cell proliferative responses to PDC-E3BP (PDHX protein) are absent or secondary to E2 responses in PBC patients, demonstrating that E3BP is not a dominant T-cell autoantigen despite being a frequent antibody target.","method":"Peripheral blood T-cell proliferation assay with purified recombinant human PDC-E2 and PDC-E3BP in 20 PBC patients and 10 controls","journal":"Liver international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional T-cell assay with defined antigen and appropriate controls; negative mechanistic finding replicated across patient cohort","pmids":["16629643"],"is_preprint":false}],"current_model":"PDHX (E3BP) is an essential structural subunit of the human pyruvate dehydrogenase complex (PDC) that forms a heterogeneous 60-meric E2/E3BP core (predominant stoichiometry 48E2+12E3BP in native complex), recruits E3 to the complex with 2:1 stoichiometry, presents its L3 lipoyl domain for interaction with PDKs (PDK1 and PDK2), and is required for PDH activity and pyruvate-to-acetyl-CoA conversion; loss-of-function mutations cause PDC deficiency with lactic acidosis, and its expression is post-transcriptionally suppressed by miR-26a, miR-27b, and miR-181b-5p, each of which targets the PDHX 3′-UTR to shift metabolism toward glycolysis in cancer contexts."},"narrative":{"mechanistic_narrative":"PDHX (E3-binding protein, E3BP) is a structural subunit of the human pyruvate dehydrogenase complex (PDC) that integrates into the heterogeneous E2/E3BP core and is required for the conversion of pyruvate to acetyl-CoA [PMID:21627584, PMID:24935220]. Within the native core, PDHX assembles with E2 in a defined stoichiometry (48E2+12E3BP) that maximizes structural flexibility while balancing E1 and E3 binding for optimal catalysis, and it recruits E3 to the complex with 2:1 stoichiometry [PMID:21627584]. Its lipoyl (L3) domain participates in the interaction with the regulatory kinases PDK1 and PDK2 within the intact E2·E3BP core [PMID:25436986]. Loss-of-function mutations in PDHX cause pyruvate dehydrogenase complex deficiency, with absence of the E3BP subunit abolishing PDH activity [PMID:16843025]. PDHX is required to maintain PDH activity and ATP production, and its expression is post-transcriptionally suppressed by miR-26a, miR-27b, and miR-181b-5p, each binding the PDHX 3′-UTR to shift metabolism toward glycolysis in cancer contexts [PMID:24935220, PMID:30012170, PMID:34485121, PMID:33964039]. PDHX is also a frequent autoantibody target in primary biliary cirrhosis, with reactivity directed exclusively to its lipoic acid-binding domain [PMID:10094940].","teleology":[{"year":1999,"claim":"Established which structural element of E3BP is the immunodominant B-cell epitope in primary biliary cirrhosis, localizing autoreactivity to a specific domain rather than the whole protein.","evidence":"Recombinant lipoic domain expression, ELISA, immunoblot, and pre-absorption with PBC patient sera","pmids":["10094940"],"confidence":"Medium","gaps":["Does not address how the lipoic domain becomes accessible/modified to trigger autoimmunity","Does not link the antibody target to disease causation"]},{"year":2006,"claim":"Demonstrated that PDHX loss-of-function causes pyruvate dehydrogenase complex deficiency, establishing the gene as essential for PDC function in humans.","evidence":"Western blot and PDHc activity assay in patient fibroblasts with a homozygous exon 10 deletion","pmids":["16843025"],"confidence":"Medium","gaps":["Single case report","Does not resolve how absence of E3BP structurally disables the core"]},{"year":2006,"claim":"Clarified that, despite being a major antibody antigen in PBC, E3BP is not a dominant T-cell autoantigen, separating humoral from cellular autoimmune targeting.","evidence":"Peripheral blood T-cell proliferation assays with purified recombinant E2 and E3BP in patients and controls","pmids":["16629643"],"confidence":"Medium","gaps":["Negative finding; does not explain the antibody/T-cell discordance mechanistically"]},{"year":2011,"claim":"Resolved the stoichiometry and assembly logic of the E2/E3BP core, showing the native 48E2+12E3BP arrangement optimizes flexibility and E1/E3 binding for catalysis.","evidence":"AUC, SANS, ITC, and mathematical modelling of recombinant and native PDC cores","pmids":["21627584"],"confidence":"High","gaps":["Does not provide an atomic-resolution structure of the assembled human core","Heterogeneity of stoichiometry in vivo not directly quantified in tissue"]},{"year":2014,"claim":"Mapped how the E2·E3BP core engages the regulatory kinases, defining domain-specific PDK1/PDK2 binding and differential conformational effects.","evidence":"HDX-MS and NMR with truncated and intact E2·E3BP core proteins","pmids":["25436986"],"confidence":"High","gaps":["Does not establish functional consequence of differential plasticity on kinase activity","PDK3/PDK4 interactions not addressed"]},{"year":2014,"claim":"Identified the first microRNA-mediated post-transcriptional control of PDHX, linking its suppression to a glycolytic metabolic shift in cancer.","evidence":"Dual-luciferase 3′-UTR reporter, Western blot/RT-PCR, and metabolite assays after miR-26a manipulation in colorectal cancer cells","pmids":["24935220"],"confidence":"Medium","gaps":["Single lab and cell-line context","In vivo relevance not tested"]},{"year":2018,"claim":"Extended the miRNA-regulation model to breast cancer, tying PDHX suppression to a measurable glycolytic flux shift and proliferation.","evidence":"Luciferase 3′-UTR reporter, Seahorse flux analysis, metabolite and proliferation assays after miR-27b manipulation","pmids":["30012170"],"confidence":"Medium","gaps":["Single lab","Does not isolate PDHX as the sole effector of the metabolic phenotype"]},{"year":2020,"claim":"Showed that the E3BP-analog assembly mechanism is not universal, with fungal protein X occupying an interior core site distinct from the mammalian E2-substituting arrangement.","evidence":"Cryo-EM reconstruction of Neurospora crassa PDC with symmetry analyses","pmids":["32938938"],"confidence":"High","gaps":["Direct structural comparison to a human core at equivalent resolution not provided","Functional consequence of fungal-specific geometry not tested"]},{"year":2021,"claim":"Connected PDHX function to cancer stemness and growth, establishing that PDHX expression sustains PDH activity, ATP output, and tumor maintenance.","evidence":"siRNA knockdown, PDH activity and ATP assays, stem-cell proliferation assays, and xenografts in ESCC; plus miR-181b-5p 3′-UTR validation and metabolic rescue in gallbladder cancer","pmids":["33964039","34485121"],"confidence":"Medium","gaps":["Co-amplification with CD44 leaves their independent contributions unresolved","Single lab per cancer context"]},{"year":null,"claim":"How PDHX integration and its regulation of kinase access dynamically tune PDC flux in different physiological and disease states remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No atomic-resolution structure of the assembled human E2/E3BP core with bound E3 and PDKs","Mechanism linking miRNA suppression to in vivo metabolic reprogramming not fully causally established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[5]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[4,5,7]}],"complexes":["pyruvate dehydrogenase complex (PDC)"],"partners":["DLAT","PDK1","PDK2","DLD"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O00330","full_name":"Pyruvate dehydrogenase protein X component, mitochondrial","aliases":["Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex","E3-binding protein","E3BP","Lipoyl-containing pyruvate dehydrogenase complex component X","proX"],"length_aa":501,"mass_kda":54.1,"function":"Required for anchoring dihydrolipoamide dehydrogenase (E3) to the dihydrolipoamide transacetylase (E2) core of the pyruvate dehydrogenase complexes of eukaryotes. This specific binding is essential for a functional PDH complex","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/O00330/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PDHX","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PDHX","total_profiled":1310},"omim":[{"mim_id":"608769","title":"PYRUVATE DEHYDROGENASE COMPLEX, COMPONENT X; PDHX","url":"https://www.omim.org/entry/608769"},{"mim_id":"602525","title":"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 2; PDK2","url":"https://www.omim.org/entry/602525"},{"mim_id":"602524","title":"PYRUVATE DEHYDROGENASE KINASE, ISOENZYME 1; PDK1","url":"https://www.omim.org/entry/602524"},{"mim_id":"312170","title":"PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD","url":"https://www.omim.org/entry/312170"},{"mim_id":"245349","title":"PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD","url":"https://www.omim.org/entry/245349"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Mitochondria","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":130.0},{"tissue":"tongue","ntpm":116.9}],"url":"https://www.proteinatlas.org/search/PDHX"},"hgnc":{"alias_symbol":["E3BP","proX","PDX1","OPDX","DLDBP"],"prev_symbol":[]},"alphafold":{"accession":"O00330","domains":[{"cath_id":"2.40.50.100","chopping":"58-133","consensus_level":"high","plddt":86.7722,"start":58,"end":133},{"cath_id":"4.10.320.10","chopping":"184-217","consensus_level":"high","plddt":87.2635,"start":184,"end":217},{"cath_id":"3.30.559.10","chopping":"301-500","consensus_level":"high","plddt":92.4325,"start":301,"end":500}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O00330","model_url":"https://alphafold.ebi.ac.uk/files/AF-O00330-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O00330-F1-predicted_aligned_error_v6.png","plddt_mean":77.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PDHX","jax_strain_url":"https://www.jax.org/strain/search?query=PDHX"},"sequence":{"accession":"O00330","fasta_url":"https://rest.uniprot.org/uniprotkb/O00330.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O00330/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O00330"}},"corpus_meta":[{"pmid":"24935220","id":"PMC_24935220","title":"MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells.","date":"2014","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24935220","citation_count":98,"is_preprint":false},{"pmid":"21194677","id":"PMC_21194677","title":"Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21194677","citation_count":67,"is_preprint":false},{"pmid":"10094940","id":"PMC_10094940","title":"Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.","date":"1999","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/10094940","citation_count":61,"is_preprint":false},{"pmid":"30012170","id":"PMC_30012170","title":"Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.","date":"2018","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30012170","citation_count":57,"is_preprint":false},{"pmid":"17152059","id":"PMC_17152059","title":"A large genomic deletion in the PDHX gene caused by the retrotranspositional insertion of a full-length LINE-1 element.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17152059","citation_count":44,"is_preprint":false},{"pmid":"32938938","id":"PMC_32938938","title":"Arrangement and symmetry of the fungal E3BP-containing core of the pyruvate dehydrogenase complex.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32938938","citation_count":24,"is_preprint":false},{"pmid":"16566017","id":"PMC_16566017","title":"Leigh's disease due to a new mutation in the PDHX gene.","date":"2006","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16566017","citation_count":24,"is_preprint":false},{"pmid":"21627584","id":"PMC_21627584","title":"Variation in the organization and subunit composition of the mammalian pyruvate dehydrogenase complex E2/E3BP core assembly.","date":"2011","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21627584","citation_count":24,"is_preprint":false},{"pmid":"31936222","id":"PMC_31936222","title":"miR-26a is Involved in Glycometabolism and Affects Boar Sperm Viability by Targeting PDHX.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31936222","citation_count":20,"is_preprint":false},{"pmid":"33964039","id":"PMC_33964039","title":"Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma.","date":"2021","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/33964039","citation_count":19,"is_preprint":false},{"pmid":"34485121","id":"PMC_34485121","title":"Downregulation of miR-181b-5p Inhibits the Viability, Migration, and Glycolysis of Gallbladder Cancer by Upregulating PDHX Under Hypoxia.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34485121","citation_count":17,"is_preprint":false},{"pmid":"25087164","id":"PMC_25087164","title":"Founder p.Arg 446* mutation in the PDHX gene explains over half of cases with congenital lactic acidosis in Roma children.","date":"2014","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25087164","citation_count":16,"is_preprint":false},{"pmid":"33634097","id":"PMC_33634097","title":"Circular RNA_PDHX Promotes the Proliferation and Invasion of Prostate Cancer by Sponging MiR-378a-3p.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33634097","citation_count":15,"is_preprint":false},{"pmid":"36889194","id":"PMC_36889194","title":"Cuproptosis-related gene PDHX and heat stress-related HSPD1 as potential key drivers associated with cell stemness, aberrant metabolism and immunosuppression in esophageal carcinoma.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36889194","citation_count":14,"is_preprint":false},{"pmid":"25436986","id":"PMC_25436986","title":"Elucidation of the interaction loci of the human pyruvate dehydrogenase complex E2·E3BP core with pyruvate dehydrogenase kinase 1 and kinase 2 by H/D exchange mass spectrometry and nuclear magnetic resonance.","date":"2014","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25436986","citation_count":14,"is_preprint":false},{"pmid":"22766002","id":"PMC_22766002","title":"Pyruvate dehydrogenase deficiency caused by a new mutation of PDHX gene in two Moroccan patients.","date":"2012","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22766002","citation_count":11,"is_preprint":false},{"pmid":"16843025","id":"PMC_16843025","title":"A novel gross deletion caused by non-homologous recombination of the PDHX gene in a patient with pyruvate dehydrogenase deficiency.","date":"2006","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16843025","citation_count":10,"is_preprint":false},{"pmid":"27343776","id":"PMC_27343776","title":"Complex genetic findings in a female patient with pyruvate dehydrogenase complex deficiency: Null mutations in the PDHX gene associated with unusual expression of the testis-specific PDHA2 gene in her somatic cells.","date":"2016","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/27343776","citation_count":4,"is_preprint":false},{"pmid":"16629643","id":"PMC_16629643","title":"PDC-E3BP is not a dominant T-cell autoantigen in primary biliary cirrhosis.","date":"2006","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/16629643","citation_count":2,"is_preprint":false},{"pmid":"39413893","id":"PMC_39413893","title":"An integrated multi-omics approach allowed ultra-rapid diagnosis of a deep intronic pathogenic variant in PDHX and precision treatment in a neonate critically ill with lactic acidosis.","date":"2024","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/39413893","citation_count":2,"is_preprint":false},{"pmid":"42093886","id":"PMC_42093886","title":"Integrating multi-omics approaches reveals metabolic reprogramming and identifies PDHX as a candidate node in triptolide-treated non-small Cell lung cancer.","date":"2026","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/42093886","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12738,"output_tokens":2543,"usd":0.038179,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9739,"output_tokens":2809,"usd":0.05946,"stage2_stop_reason":"end_turn"},"total_usd":0.097639,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"The human PDC E2/E3BP core exists as a heterogeneous population of assemblies; recombinant core produced with excess E3BP yields 40E2+20E3BP stoichiometry, while native bovine core is 48E2+12E3BP. Both cores bind E3 with 2:1 stoichiometry, and mathematical modelling indicates 48E2+12E3BP maximizes flexibility while balancing E1 and E3 binding for optimal catalysis.\",\n      \"method\": \"Analytical ultracentrifugation, small-angle neutron scattering, isothermal titration calorimetry, and mathematical modelling of recombinant and native PDC core assemblies\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with multiple orthogonal biophysical methods (AUC, SANS, ITC) in a single rigorous study\",\n      \"pmids\": [\"21627584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The E2·E3BP core interacts with PDK1 and PDK2 at defined loci: the L2 lipoyl domain of E2 preferentially binds PDK2 over PDK1 in the context of the intact core; L3 of E3BP shows moderate interaction with both PDKs. The intact E2·E3BP core induces greater conformational plasticity in PDK1 than PDK2.\",\n      \"method\": \"H/D exchange mass spectrometry (HDX-MS) and NMR with truncated and intact E2·E3BP core proteins\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — two orthogonal structural/biophysical methods (HDX-MS and NMR) applied to the same protein complex in one study\",\n      \"pmids\": [\"25436986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In the fungal PDC ortholog, protein X (PX; functional analog of mammalian E3BP) is located interior to the PDC core rather than substituting E2 subunits as in mammals; steric occlusion limits PX binding, resulting in predominantly tetrahedral symmetry. The PX-binding site is conserved in and specific to fungi, distinct from the mammalian E3BP mechanism.\",\n      \"method\": \"Cryo-electron microscopy reconstruction of Neurospora crassa PDC\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure with multiple symmetry analyses revealing mechanistic distinction from mammalian E3BP\",\n      \"pmids\": [\"32938938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Autoantibodies in primary biliary cirrhosis (PBC) directed against E3BP (PDHX) are targeted exclusively to its lipoic acid-binding domain; pre-absorption of patient sera with the E3BP lipoic domain completely abolished all reactivity with the full-length protein.\",\n      \"method\": \"Recombinant protein expression of E3BP lipoic domain, ELISA, immunoblotting, and pre-absorption experiments with PBC patient sera\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal serology (ELISA + immunoblot + absorption) in a single study with 45 PBC and 52 control sera\",\n      \"pmids\": [\"10094940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"miR-26a directly binds the 3′-UTR of PDHX mRNA and suppresses PDHX expression, resulting in reduced conversion of pyruvate to acetyl-CoA (decreased acetyl-CoA, increased pyruvate accumulation) in colorectal cancer cells.\",\n      \"method\": \"Dual-luciferase reporter assay for 3′-UTR targeting; Western blot and RT-PCR for protein/mRNA; metabolite assays (glucose consumption, lactate, pyruvate, acetyl-CoA) after miR-26a overexpression or inhibition in HCT116 cells\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter confirms direct 3′-UTR targeting plus multiple metabolite readouts; single lab\",\n      \"pmids\": [\"24935220\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"miR-27b directly targets PDHX mRNA via its 3′-UTR and suppresses PDHX protein expression in breast cancer cells, shifting metabolism toward glycolysis (increased lactate, decreased citrate and mitochondrial oxidation) and promoting cell proliferation.\",\n      \"method\": \"Luciferase 3′-UTR reporter assay; RT-PCR; Western blot; Seahorse metabolic flux analysis; metabolite assays; cell proliferation assays after miR-27b manipulation\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct 3′-UTR validation plus orthogonal metabolic readouts; single lab\",\n      \"pmids\": [\"30012170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-181b-5p directly targets PDHX mRNA (validated by dual-luciferase reporter assay), and its inhibition upregulates PDHX protein, reversing hypoxia-induced increases in glucose consumption and lactate production in gallbladder cancer cells.\",\n      \"method\": \"Dual-luciferase reporter assay; Western blot; glucose and lactate metabolite assays; CCK-8 viability and Transwell migration assays after miR-181b-5p antagomir treatment\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct 3′-UTR targeting confirmed plus metabolic phenotype rescue; single lab\",\n      \"pmids\": [\"34485121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PDHX expression is required for maintenance of pyruvate dehydrogenase (PDH) activity and ATP production in esophageal squamous cell carcinoma (ESCC); PDHX knockdown inhibits cancer stem cell proliferation and in vivo tumor growth. PDHX and CD44 are co-amplified at 11p13 and coordinately support cancer stemness.\",\n      \"method\": \"siRNA knockdown of PDHX; PDH activity assay; ATP production assay; cancer stem cell proliferation assay; in vivo xenograft tumor growth experiments\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with enzymatic activity readout plus in vivo validation; single lab\",\n      \"pmids\": [\"33964039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Loss-of-function mutations in PDHX (encoding E3-binding protein/E3BP) cause pyruvate dehydrogenase complex deficiency; the E3BP subunit is undetectable by Western blot in patient fibroblasts carrying a homozygous deletion of exon 10 (3913 bp deletion in PDHX).\",\n      \"method\": \"Western blot of patient-derived fibroblasts; long-range PCR; direct sequencing of deletion breakpoints; PDHc activity assay\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Western blot absence of protein plus enzyme activity assay; single case report\",\n      \"pmids\": [\"16843025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"T-cell proliferative responses to PDC-E3BP (PDHX protein) are absent or secondary to E2 responses in PBC patients, demonstrating that E3BP is not a dominant T-cell autoantigen despite being a frequent antibody target.\",\n      \"method\": \"Peripheral blood T-cell proliferation assay with purified recombinant human PDC-E2 and PDC-E3BP in 20 PBC patients and 10 controls\",\n      \"journal\": \"Liver international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional T-cell assay with defined antigen and appropriate controls; negative mechanistic finding replicated across patient cohort\",\n      \"pmids\": [\"16629643\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PDHX (E3BP) is an essential structural subunit of the human pyruvate dehydrogenase complex (PDC) that forms a heterogeneous 60-meric E2/E3BP core (predominant stoichiometry 48E2+12E3BP in native complex), recruits E3 to the complex with 2:1 stoichiometry, presents its L3 lipoyl domain for interaction with PDKs (PDK1 and PDK2), and is required for PDH activity and pyruvate-to-acetyl-CoA conversion; loss-of-function mutations cause PDC deficiency with lactic acidosis, and its expression is post-transcriptionally suppressed by miR-26a, miR-27b, and miR-181b-5p, each of which targets the PDHX 3′-UTR to shift metabolism toward glycolysis in cancer contexts.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PDHX (E3-binding protein, E3BP) is a structural subunit of the human pyruvate dehydrogenase complex (PDC) that integrates into the heterogeneous E2/E3BP core and is required for the conversion of pyruvate to acetyl-CoA [#0, #4]. Within the native core, PDHX assembles with E2 in a defined stoichiometry (48E2+12E3BP) that maximizes structural flexibility while balancing E1 and E3 binding for optimal catalysis, and it recruits E3 to the complex with 2:1 stoichiometry [#0]. Its lipoyl (L3) domain participates in the interaction with the regulatory kinases PDK1 and PDK2 within the intact E2·E3BP core [#1]. Loss-of-function mutations in PDHX cause pyruvate dehydrogenase complex deficiency, with absence of the E3BP subunit abolishing PDH activity [#8]. PDHX is required to maintain PDH activity and ATP production, and its expression is post-transcriptionally suppressed by miR-26a, miR-27b, and miR-181b-5p, each binding the PDHX 3′-UTR to shift metabolism toward glycolysis in cancer contexts [#4, #5, #6, #7]. PDHX is also a frequent autoantibody target in primary biliary cirrhosis, with reactivity directed exclusively to its lipoic acid-binding domain [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established which structural element of E3BP is the immunodominant B-cell epitope in primary biliary cirrhosis, localizing autoreactivity to a specific domain rather than the whole protein.\",\n      \"evidence\": \"Recombinant lipoic domain expression, ELISA, immunoblot, and pre-absorption with PBC patient sera\",\n      \"pmids\": [\"10094940\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not address how the lipoic domain becomes accessible/modified to trigger autoimmunity\", \"Does not link the antibody target to disease causation\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated that PDHX loss-of-function causes pyruvate dehydrogenase complex deficiency, establishing the gene as essential for PDC function in humans.\",\n      \"evidence\": \"Western blot and PDHc activity assay in patient fibroblasts with a homozygous exon 10 deletion\",\n      \"pmids\": [\"16843025\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single case report\", \"Does not resolve how absence of E3BP structurally disables the core\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Clarified that, despite being a major antibody antigen in PBC, E3BP is not a dominant T-cell autoantigen, separating humoral from cellular autoimmune targeting.\",\n      \"evidence\": \"Peripheral blood T-cell proliferation assays with purified recombinant E2 and E3BP in patients and controls\",\n      \"pmids\": [\"16629643\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative finding; does not explain the antibody/T-cell discordance mechanistically\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved the stoichiometry and assembly logic of the E2/E3BP core, showing the native 48E2+12E3BP arrangement optimizes flexibility and E1/E3 binding for catalysis.\",\n      \"evidence\": \"AUC, SANS, ITC, and mathematical modelling of recombinant and native PDC cores\",\n      \"pmids\": [\"21627584\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not provide an atomic-resolution structure of the assembled human core\", \"Heterogeneity of stoichiometry in vivo not directly quantified in tissue\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Mapped how the E2·E3BP core engages the regulatory kinases, defining domain-specific PDK1/PDK2 binding and differential conformational effects.\",\n      \"evidence\": \"HDX-MS and NMR with truncated and intact E2·E3BP core proteins\",\n      \"pmids\": [\"25436986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not establish functional consequence of differential plasticity on kinase activity\", \"PDK3/PDK4 interactions not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified the first microRNA-mediated post-transcriptional control of PDHX, linking its suppression to a glycolytic metabolic shift in cancer.\",\n      \"evidence\": \"Dual-luciferase 3′-UTR reporter, Western blot/RT-PCR, and metabolite assays after miR-26a manipulation in colorectal cancer cells\",\n      \"pmids\": [\"24935220\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab and cell-line context\", \"In vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended the miRNA-regulation model to breast cancer, tying PDHX suppression to a measurable glycolytic flux shift and proliferation.\",\n      \"evidence\": \"Luciferase 3′-UTR reporter, Seahorse flux analysis, metabolite and proliferation assays after miR-27b manipulation\",\n      \"pmids\": [\"30012170\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Does not isolate PDHX as the sole effector of the metabolic phenotype\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed that the E3BP-analog assembly mechanism is not universal, with fungal protein X occupying an interior core site distinct from the mammalian E2-substituting arrangement.\",\n      \"evidence\": \"Cryo-EM reconstruction of Neurospora crassa PDC with symmetry analyses\",\n      \"pmids\": [\"32938938\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct structural comparison to a human core at equivalent resolution not provided\", \"Functional consequence of fungal-specific geometry not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected PDHX function to cancer stemness and growth, establishing that PDHX expression sustains PDH activity, ATP output, and tumor maintenance.\",\n      \"evidence\": \"siRNA knockdown, PDH activity and ATP assays, stem-cell proliferation assays, and xenografts in ESCC; plus miR-181b-5p 3′-UTR validation and metabolic rescue in gallbladder cancer\",\n      \"pmids\": [\"33964039\", \"34485121\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-amplification with CD44 leaves their independent contributions unresolved\", \"Single lab per cancer context\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PDHX integration and its regulation of kinase access dynamically tune PDC flux in different physiological and disease states remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No atomic-resolution structure of the assembled human E2/E3BP core with bound E3 and PDKs\", \"Mechanism linking miRNA suppression to in vivo metabolic reprogramming not fully causally established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [4, 5, 7]}\n    ],\n    \"complexes\": [\"pyruvate dehydrogenase complex (PDC)\"],\n    \"partners\": [\"DLAT\", \"PDK1\", \"PDK2\", \"DLD\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}